A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer.

Cescon, David W; Hilton, John; Morales Murilo, Serafin; Layman, Rachel M; Pluard, Timothy; Yeo, Belinda; Park, In Hae; Provencher, Louise; Kim, Sung-Bae; Im, Young-Hyuck; Wyce, Anastasia; Krishnatry, Anu Shilpa; Hicks, Kirsty; Zhang, Qu; Barbash, Olena; Khaled, Ahmed; Horner, Thierry; Dhar, Arindam; Oliveira, Mafalda; Sparano, Joseph A

Cescon, David W; Hilton, John; Morales Murilo, Serafin; Layman, Rachel M; Pluard, Timothy; Yeo, Belinda; Park, In Hae; Provencher, Louise; Kim, Sung-Bae; Im, Young-Hyuck; Wyce, Anastasia; Krishnatry, Anu Shilpa; Hicks, Kirsty; Zhang, Qu; Barbash, Olena; Khaled, Ahmed; Horner, Thierry; Dhar, Arindam; Oliveira, Mafalda; Sparano, Joseph A.

Affiliation

Cescon DW; Princess Margaret Cancer Center, University Health Network and University of Toronto, Toronto, Ontario, Canada.
Hilton J; Ottawa Hospital Cancer Center, Ottawa, Ontario, Canada.
Morales Murilo S; Lleida Biomedical Research Institute, Lleida, Spain.
Layman RM; MD Anderson Cancer Center, Houston, Texas.
Pluard T; Saint Luke's Cancer Institute, Kansas City, Missouri.
Yeo B; Olivia Newton-John Cancer Research and Wellness Centre and Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, Australia.
Park IH; National Cancer Center, Goyang, Republic of South Korea.
Provencher L; Korea University Guro Hospital, Seoul, Republic of South Korea.
Kim SB; CHU de Québec-Laval University, Québec City, Québec, Canada.
Im YH; Asan Medical Center, Seoul, Republic of South Korea.
Wyce A; Samsung Medical Center, Seoul, Republic of South Korea.
Krishnatry AS; GSK, Collegeville, Pennsylvania.
Hicks K; GSK, Collegeville, Pennsylvania.
Zhang Q; GSK, Collegeville, Pennsylvania.
Barbash O; GSK, Collegeville, Pennsylvania.
Khaled A; GSK, Collegeville, Pennsylvania.
Horner T; GSK, Collegeville, Pennsylvania.
Dhar A; GSK, Collegeville, Pennsylvania.
Oliveira M; GSK, Collegeville, Pennsylvania.
Sparano JA; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.

Clin Cancer Res ; 30(2): 334-343, 2024 01 17.

Article in En | MEDLINE | ID: mdl-37992310

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzodiazepines / Breast Neoplasms Limits: Female / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Country of publication:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google